Suchergebnisse - "Milella, Michele"

PubPharm (641)

1

PARP Inhibitors in Metastatic Prostate Cancer : A Comprehensive Systematic Review and Meta-analysis of Existing Evidence

enthalten in: Clinical genitourinary cancer | 2024

von Ditonno, F. | Bianchi, A. | Malandra, S. | +10

2

Stage Classification and Prognosis Assessment in Localized Pancreatic Cancer : It Takes Two to Tango

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Milella, M.

3

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy : the ARON-2 study

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Massari, F. | Santoni, M. | Takeshita, H. | +94

4

What is the role of physical exercise in the era of cancer prehabilitation? A systematic review

enthalten in: Critical reviews in oncology/hematology | 2024

von Del Bianco, N. | Borsati, A. | Toniolo, L. | +8

5

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

enthalten in: Cancer immunology immunotherapy | 2024

von Massari, F. | Santoni, M. | Takeshita, H. | +94

6

Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study

enthalten in: European urology | 2024

von Iacovelli, R. | Ciccarese, C. | Buti, S. | +22

7

The endocrine disruptor cadmium modulates the androgen-estrogen receptors ratio and induces inflammatory cytokines in luminal (A) cell models of breast cancer

enthalten in: Endocrine | 2024

von Bimonte, V. | Catanzaro, G. | Po, A. | +10

8

Accessible Machine Learning and Deep Learning Models Predict Response and Survival in Early Stage Hormone Receptor-Positive/HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy

enthalten in: ResearchSquare.com | 2024

von Garufi, G. | Mastrantoni, L. | Giordano, G. | +27

9

Author Correction : Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities

enthalten in: Cell discovery | 2024

von Pulito, C. | Mori, F. | Sacconi, A. | +16

ErratumFor: Cell Discov. 2017 Jul 04;3:17022. - PMID 28698800

10

Feasibility of a novel exercise program for patients with breast cancer offering different modalities and based on patient preference

enthalten in: European journal of oncology nursing : the official journal of European Oncology Nursing Society | 2024

von Borsati, A. | Toniolo, L. | Trestini, I. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[65]